Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
---|
05/10/2011 | CA2593659C Method of screening for carcinoma and adenoma |
05/10/2011 | CA2555359C Fingerprinting of complex hydrocarbon containing mixtures |
05/10/2011 | CA2536024C Method and apparatus for assessing or predicting the characteristics of wood |
05/10/2011 | CA2518066C Diagnosis of autism |
05/10/2011 | CA2498352C A method for the identification of drug targets |
05/10/2011 | CA2487388C Compounds that abrogate dna-damage-induced cell cycle g2 checkpoint and/or augment the anti-cancer activity of dna-damaging treatments |
05/10/2011 | CA2483105C Autoimmune conditions and nadph oxidase defects |
05/10/2011 | CA2478016C Presynaptic protein p120 |
05/10/2011 | CA2464987C Aequorin as a reporter gene in yeast |
05/10/2011 | CA2455805C Compounds and methods for therapeutic intervention in preventing diabetic complications |
05/10/2011 | CA2451378C Assay for measuring factor viia-antithrombin complexes |
05/10/2011 | CA2439170C Methods for identifying compounds for regulating muscle mass or function using corticotropin releasing factor receptors |
05/10/2011 | CA2417104C Use of monodispersed polymer particles for measuring the adhesivity of platelets in vivo |
05/10/2011 | CA2416293C Somatostatin analogues |
05/10/2011 | CA2415460C Widely applicable process for identifying modulators of g-protien-coupled receptors |
05/10/2011 | CA2411056C Pharmaceutical compositions containing prostacyclin synthase gene |
05/10/2011 | CA2401852C Dna molecules encoding a glutamate-gated chloride channel in drosophila melanogaster |
05/10/2011 | CA2388272C Electrochemical test strip for use in analyte determination |
05/10/2011 | CA2387576C Immuno-interactive fragments of the .alpha.c subunit of inhibin |
05/10/2011 | CA2375605C Peptide leukotriene receptor |
05/10/2011 | CA2361249C Enriched central nervous system stem cell and progenitor cell populations, and methods for identifying, isolating and enriching for such populations |
05/10/2011 | CA2344590C Treatment of inflammatory disease |
05/10/2011 | CA2342979C Chemiluminescent 1,2-dioxetanes |
05/10/2011 | CA2323812C Early pregnancy diagnosis using pags (pregnancy-associated glycoproteins) |
05/10/2011 | CA2318789C Cellular arrays for rapid molecular profiling |
05/10/2011 | CA2314996C Carbohydrate oxidase and use thereof in baking |
05/10/2011 | CA2311479C Procedure for the determination of the activity of the protease which activates factor vii from protein solutions |
05/10/2011 | CA2310684C Continuous format high throughput screening |
05/10/2011 | CA2304810C Tie receptor tyrosine kinase ligand homologues |
05/10/2011 | CA2292898C Bacterial pheromones and uses therefor |
05/10/2011 | CA2283758C Spinocerebellar ataxia type 8 and methods of detection |
05/10/2011 | CA1341613C Assays utilizing improved chemiluminescent esters, thioesters and amides |
05/06/2011 | CA2725359A1 Filter wheel source assembly for downhole spectroscopy |
05/05/2011 | WO2011053971A2 Method for enhancing the sensitivity of antibody based assays |
05/05/2011 | WO2011053944A2 Gfp mutagenesis amplification: use of a flourescence-antibiotic resistance fusion dual reporter construct to provide quantitative and highly sensitive detection of mutations |
05/05/2011 | WO2011053907A2 Human omental mesothelial cells, methods of isolation and uses thereof |
05/05/2011 | WO2011053901A2 Magnetic nanostructures as theranostic agents |
05/05/2011 | WO2011053894A2 Methods and apparatus for binding assays |
05/05/2011 | WO2011053866A1 Combustible gas sensors including integral support structures and combustible gas sensor with multiple active elements |
05/05/2011 | WO2011053845A2 Microvessels, microparticles, and methods of manufacturing and using the same |
05/05/2011 | WO2011053832A1 Use of urinary ngal to diagnose sepsis in very low birth weight infants |
05/05/2011 | WO2011053823A1 A melanoma prognostic model using tissue microarrays and genetic algorithms |
05/05/2011 | WO2011053777A1 Use of immunoregulatory nk cell populations for predicting the efficacy of anti-il-2r antibodies in multiple sclerosis patients |
05/05/2011 | WO2011053743A1 Pcsk9 immunoassay |
05/05/2011 | WO2011053721A1 Electrochemical sensors including electrodes with diffusion barriers |
05/05/2011 | WO2011053666A1 Method of predicting risk of preterm birth |
05/05/2011 | WO2011053665A1 Pcsk9 immunoassay |
05/05/2011 | WO2011053587A1 Composition, device and method for colorimetric detection of an analyte using imprinted polymers and photochromic switch molecules |
05/05/2011 | WO2011053565A2 Compositions and methods for detecting a tauopathy |
05/05/2011 | WO2011053247A1 Method for the detection of an analyte by surface enhanced raman spectroscopy (sers) |
05/05/2011 | WO2011053110A2 An integrated packaged environmental sensor and roic and a method of fabricating the same |
05/05/2011 | WO2011052910A2 Kit for centrifugal separation, and centrifugal separation method using same |
05/05/2011 | WO2011052906A2 Use of eif3m for the diagnosis and treatment of cancer |
05/05/2011 | WO2011052752A1 Device comprising foldable structural object |
05/05/2011 | WO2011052750A1 Anticancer agent sensitivity-determining marker |
05/05/2011 | WO2011052749A1 Method for determination of sensitivity to anti-cancer agent |
05/05/2011 | WO2011052748A1 Method for determining sensitivity to an anticancer agent |
05/05/2011 | WO2011052620A1 Method for assaying component to be assayed in specimen and assay kit |
05/05/2011 | WO2011052592A1 Method for evaluating risk of inducing onset of atopic dermatitis by breast milk or food or drink, and breast milk or food or drink with reduced risk of inducing onset of atopic dermatitis |
05/05/2011 | WO2011052586A1 Method for detection of target nucleic acid |
05/05/2011 | WO2011052522A1 Diagnostic agent for infectious diseases |
05/05/2011 | WO2011052486A1 Immunological assay and immunological assay kit |
05/05/2011 | WO2011052380A1 5.9 kDa PEPTIDE IMMUNOASSAY METHOD |
05/05/2011 | WO2011052244A1 A method for analyzing PSA, and a method for distinguishing prostate cancer from prostatic hypertrophy using that method for analyzing PSA |
05/05/2011 | WO2011052196A1 Tissue array manufacturing device |
05/05/2011 | WO2011052139A1 Fuel property detection device for construction equipment and construction equipment provided therewith |
05/05/2011 | WO2011052052A1 Apparatus for detecting fuel decay in internal combustion engine |
05/05/2011 | WO2011051792A1 System for predicting the percentage of graphitization in specific areas of pieces of vermicular graphite cast iron |
05/05/2011 | WO2011051709A1 A proximity ligation assay involving generation of catalytic activity |
05/05/2011 | WO2011051577A1 Method and system for determining the quality of the atmosphere of an inside environment |
05/05/2011 | WO2011051574A1 Method for producing implantable medical bioprostheses having reduced calcification properties |
05/05/2011 | WO2011051562A1 Membranes for lateral flow assay |
05/05/2011 | WO2011051534A1 Improved electrolytic respirometer for measuring the stability of an agricultural compost |
05/05/2011 | WO2011051307A1 Dosage regimen for administering a cd19xcd3 bispecific antibody |
05/05/2011 | WO2011051288A1 Podxl protein in colorectal cancer |
05/05/2011 | WO2011051280A1 Ovary tumor markers and methods of use thereof |
05/05/2011 | WO2011051278A1 Lung tumor markers and methods of use thereof |
05/05/2011 | WO2011051277A1 Breast tumor markers and methods of use thereof |
05/05/2011 | WO2011051276A1 Colon and rectal tumor markers and methods of use thereof |
05/05/2011 | WO2011051271A2 Prostate tumor markers and methods of use thereof |
05/05/2011 | WO2011051225A1 Process for synthesizing epicocconone analogs |
05/05/2011 | WO2011050968A1 Method for the direct measure of molecular interactions by detection of light reflected from multilayered functionalized dielectrics |
05/05/2011 | WO2011050955A1 Antagonists and agonists of bitter taste receptors and uses thereof |
05/05/2011 | WO2011050463A1 Analyte quantification multiplex microarrays combining internal and external calibration |
05/05/2011 | WO2011050459A1 Methods and uses for treating hepatic ischemia and reperfusion injury |
05/05/2011 | WO2011050436A1 Particle size distribution determination apparatus and method |
05/05/2011 | WO2011050407A1 Methods of diagnosing and prognosing colonic polyps |
05/05/2011 | WO2011050384A2 Pharmaceutical composition for the treatment and prevention of a rhinovirus infection |
05/05/2011 | WO2011050379A1 Use of gstp1 |
05/05/2011 | WO2011030313A3 A method for detecting an analyte |
05/05/2011 | WO2011028535A3 System for rapid high-resolution gel electrophoresis |
05/05/2011 | WO2011015944A3 Use of free dna as an early predictor of severity in acute pancreatitis |
05/05/2011 | WO2011014879A3 Assay tools and methods of use |
05/05/2011 | WO2011013111A3 Pressure measurement of a reservoir fluid in a microfluidic device |
05/05/2011 | WO2011009771A3 Immunogenic and therapeutic compositions for streptococcus suis |
05/05/2011 | WO2011008518A3 Methods and apparatus for the detection and differentiation of non-sialated proteins from sialated proteins in a fluid sample |
05/05/2011 | WO2011005570A3 Systems and methods for treating, diagnosing and predicting the response to therapy of breast cancer |
05/05/2011 | WO2011003623A3 Method and marker for the individual prognosis and/or the individual detection of neuropathy |
05/05/2011 | WO2011002251A3 Marker for predicting fertility |
05/05/2011 | WO2010151761A3 Method for identifying and tracking tissue samples and histological preparations |